Juris J Meier
20PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Jul 02, 2024
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes.Daniel R Quast, Dara Lancaster, Cong Xie
|Oct 19, 2023
Increased incidence of GERD in GLP-1 treated patients: fact or artefact?Daniel Robert Quast, Juris J Meier
|Aug 08, 2023
The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.Laerke S Gasbjerg, Mette M Rosenkilde, Juris J Meier
|Jan 26, 2023
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.Vanita R Aroda, Umut Erhan, Peter Jelnes
|Dec 23, 2022
Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.Juris J Meier, Lars Bardtrum, Alice Y Y Cheng
|Apr 04, 2022
Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.Vanita R Aroda, Robert Bauer, Erik Christiansen
Pageof 4
Frequent Collaborators
8 joint publications
Michael A Nauck
6 joint publications
Daniel Robert Quast
5 joint publications
Christoph Kapitza
2 joint publications
Jens J Holst
2 joint publications
Julio Rosenstock
2 joint publications
Eduard Montanya
2 joint publications
Richard Pratley
2 joint publications
Vanita R Aroda
1 joint publications
Francesco Giorgino
1 joint publications
Christopher K Rayner
